Бастиан Блоэм - Нестареющее тело. Научное исследование о том, как защитить свои тело и мозг и не допустить развития неврологических заболеваний

22. Trichloroethylene. US Environmental Protection Agency. April 1992. www.epa.gov/sites/ production/files/2016-09/documents/ trichloroethylene.pdf. Updated January 2000. Accessed March 28, 2019.

23. Trichloroethylene (TCE) general fact sheet. In Agency for Toxic Substances and Disease Registry, US Department of Health and Human Services. www.gsa.gov/cdnstatic/ Trichloroethylene_%28TCE%29_ NEW_general_fact_sheet.pdf. Accessed March 29, 2019.

24. Risk management for trichloroethylene (TCE). US Environmental Protection Agency. www.epa.gov/assessing-and-managing-chemicals-under-tsca/risk-management-trichloroethylene-tce. Updated December 14, 2017. Accessed November 16, 2018; Integrated Risk Information System: trichloroethylene. US Environmental Protection Agency. https:// cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=199. Updated July 28, 2017. Accessed March 28, 2019.

25. Watts M. Paraquat. Pesticide Action Network Asia & the Pacific. February 2011. www.panna.org/sites/default/files/Paraquat%20 monograph%20final%202011-1.pdf. Accessed June 28, 2019; China about to ban all sales and use of paraquat by 2020 [пресс-релиз]. CCM Data & Business Intelligence, July 31, 2017. www.cnchemicals. com/Press/89866-China%20 about%20to%20ban%20all%20sales%20 and%20use%20of%20paraquat%20by%202020.html. Accessed June 28, 2019.

26. Tanner CM, Kamel F, Ross GW, et al. Rotenone, paraquat, and Parkinson’s disease. Environmental Health Perspectives. 2011;119(6):866–872.

27. Pesticide National Synthesis Project: estimated annual agricultural pesticide use. US Geological Survey. https://water.usgs.gov/nawqa/pnsp/ usage /maps/show_map.php? year=2015&map=PARAQUAT&hilo=H. Updated September 11, 2018. Accessed March 25, 2019.

28. Jenkins D. Court grants EPA new hearing on pesticide ban. Capital Press. February 12, 2019; O’Neill E. Will an appeals court make the EPA ban a pesticide linked to serious health risks? The Salt. February 26, 2019. www.npr.org/sections/thesalt/2019/02/26/698227414/will-an-appeals-court-make-the-epa-ban-a-pesticide-linked-to-serious-health-risk. Accessed June 28, 2019.

29. Friedman L. E.P.A. won’t ban chlorpyrifos, pesticide tied to children’s health problems. New York Times. July 18, 2019. www. nytimes.com/2019/07/18/climate/epa-chlorpyrifos-pesticide-ban. html?smid=nytcore-ios-share.

30. Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. American Journal of Human Genetics. 1998;62(3):676–689; Danaei G, Vander Hoorn S, Lopez AD, Murray CJL, Ezzati M. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. The Lancet. 2005;366(9499):1784–1793; Brody JG, Moysich KB, Humblet O, Attfield KR, Beehler GP, Rudel RA. Environmental pollutants and breast cancer. Cancer. 2007; 109(S12):2667–2711; McPherson K, Steel CM, Dixon JM. ABC of breast diseases. Breast cancer – epidemiology, risk factors, and genetics. BMJ. 2000;321(7261):624–628.

31. Hofman A, Stricker BH, Ikram MA, Koudstaal PJ, Darweesh SKL. Trends in the incidence of Parkinson disease in the general population: the Rotterdam Study. American Journal of Epidemiology. 2016;183(11):1018–1026.

32. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson’s disease. Nature Neuroscience. 2000;3(12):1301–1306.

33. Okun MS. Parkinson’s Treatment: 10 Secrets to a Happier Life (CreateSpace, 2013)/«10 секретов надежды и счастливой жизни с болезнью Паркинсона» Майкл Окун (фрагмент книги опубликован в интернете); Okun MS, Gallo BV, Mandybur G, et al. Subthalamic deep brain stimulation with a constant-current device in Parkinson’s disease: an open-label randomised controlled trial. Lancet Neurology . 2012;11(2):140–149; Okun MS, Fernandez HH, Wu SS, et al. Cognition and mood in Parkinson’s disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE Trial. Annals of Neurology. 2009;65(5): 586–595; Okun MS. Ask the Doctor About Parkinson’s Disease. 1st ed. Demos Health; 2009. Okun MS. 10 Breakthrough Therapies for Parkinsons Disease: English Edition. 1st ed. Books4Patients; 2015.

34. Bloem BR, Hausdorff JM, Visser JE, Giladi N. Falls and freezing of gait in Parkinson’s disease: a review of two interconnected, episodic phenomena. Movement Disorders. 2004; 19(8):871–884; Bloem BR, Grimbergen YAM, Cramer M, Willemsen M, Zwinderman AH. Prospective assessment of falls in Parkinson’s disease. Journal of Neurology. 2001;248(11):950–958; Nijkrake MJ, Keus SHJ, Overeem S, et al. The ParkinsonNet concept: development, implementation and initial experience. Movement Disorders. 2010;25(7):823–829; Bloem BR, Rompen L, de Vries NM, Klink A, Munneke M, Jeurissen P. ParkinsonNet: a low-cost health care innovation with a systems approach from the Netherlands. Health Affairs. 2017;36:1987–1996.

35. Beck CA, Beran DB, Biglan KM, et al. National randomized controlled trial of virtual house calls for Parkinson disease. Neurology . 2017;89(11):1152–1161; Dorsey ER, Venkataraman V, Grana MJ, et al. Randomized controlled clinical trial of “virtual house calls” for Parkinson disease. JAMA Neurology. 2013;70(5):565–570.

1. Parkinson J. An essay on the shaking palsy. Journal of Neuropsychiatry and Clinical Neurosciences. 2002;14(2):223–236.

2. Morris AD, Rose FC. James Parkinson: His Life and Times . Boston: Birkhauser; 1989.

3. Blake, W The Poetical Works of William Blake, ed. by John Sampson. London, New York: Oxford University Press, 1908; Bartleby.com, 2011. www.bartleby.com/235/284.html.

4. Ritchie H. What the history of London’s air pollution can tell us about the future of today’s growing megacities. Our World in Data. June 20, 2017. https://ourworldindata.org/london-air-pollution. Accessed December 12, 2018.

5. Там же.

6. Morris AD, Rose FC. James Parkinson: His Life and Times. Birkhauser; 1989.

7. Там же.

8. Там же.

9. Там же.

10. Zhang Z, Dong Z, Roman GC. Early descriptions of Parkinson disease in ancient China. Archives of Neurology. 2006;63(5):782–784; Ovallath S, Deepa P. The history of parkinsonism: descriptions in ancient Indian medical literature. Movement Disorders. 2013;28(5):566–568; Obeso JA, Stamelou M, Goetz CG, et al. Past, present, and future of Parkinson’s disease: a special essay on the 200th anniversary of the shaking palsy. Movement Disorders. 2017;32(9):1264–1310; Lees AJ. Unresolved issues relating to the shaking palsy on the celebration of James Parkinson’s 250th birthday. Movement Disorders . 2007;22(S17):S327-S334.

11. Zhang Z, Dong Z, Roman GC. Early descriptions of Parkinson disease in ancient China. Archives of Neurology . 2006;63(5):782–784; Ovallath S, Deepa P. The history of parkinsonism: descriptions in ancient Indian medical literature. Movement Disorders. 2013;28(5):566–568.

12. Obeso JA, Stamelou M, Goetz CG, et al. Past, present, and future of Parkinson’s disease: a special essay on the 200th anniversary of the shaking palsy. Movement Disorders. 2017;32(9):1264–1310.

13. Goetz CG. The history of Parkinson’s disease: early clinical descriptions and neurological therapies. Cold Spring Harbor Perspectives in Medicine. 2011;1(1):a008862.